YU43006B - Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof - Google Patents

Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof

Info

Publication number
YU43006B
YU43006B YU592/81A YU59281A YU43006B YU 43006 B YU43006 B YU 43006B YU 592/81 A YU592/81 A YU 592/81A YU 59281 A YU59281 A YU 59281A YU 43006 B YU43006 B YU 43006B
Authority
YU
Yugoslavia
Prior art keywords
deoxo
aza
derivatives
methyl
preparing
Prior art date
Application number
YU592/81A
Other languages
English (en)
Other versions
YU59281A (en
Inventor
G Kobrehel
S Djokic
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25550598&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU43006(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Priority to YU592/81A priority Critical patent/YU43006B/xx
Priority to SI8110592A priority patent/SI8110592A8/sl
Priority to US06/304,481 priority patent/US4517359A/en
Priority to GB8130256A priority patent/GB2094293B/en
Priority to DE3140449A priority patent/DE3140449C2/de
Priority to AT0440081A priority patent/AT375945B/de
Priority to JP56189381A priority patent/JPS5858357B2/ja
Priority to SE8201311A priority patent/SE457084B/sv
Priority to CA000397477A priority patent/CA1191843A/en
Priority to BE0/207464A priority patent/BE892357A/fr
Priority to DD82237882A priority patent/DD202437A5/de
Priority to FR8203601A priority patent/FR2501212B1/fr
Priority to IT67263/82A priority patent/IT1200960B/it
Priority to PL1982244022A priority patent/PL133764B1/pl
Priority to SU823402600A priority patent/SU1287755A3/ru
Priority to HU82683A priority patent/HU186845B/hu
Priority to PL1982235329A priority patent/PL131784B1/pl
Priority to CH1363/82A priority patent/CH655728A5/de
Publication of YU59281A publication Critical patent/YU59281A/xx
Publication of YU43006B publication Critical patent/YU43006B/xx
Priority to SK4189-91A priority patent/SK418991A3/sk
Priority to CS914189A priority patent/CZ418991A3/cs
Priority to HRP-592/81A priority patent/HRP930015B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
YU592/81A 1981-03-06 1981-03-06 Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof YU43006B (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
YU592/81A YU43006B (en) 1981-03-06 1981-03-06 Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
SI8110592A SI8110592A8 (en) 1981-03-06 1981-03-06 Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US06/304,481 US4517359A (en) 1981-03-06 1981-09-22 11-Methyl-11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one and derivatives thereof
GB8130256A GB2094293B (en) 1981-03-06 1981-10-07 New erythromycin a derivatives a process for their manufacture and their use in the control of bacteria
DE3140449A DE3140449C2 (de) 1981-03-06 1981-10-12 N-Methyl-11-aza-10-deoxo-10-dihydro-erythromycine A, Verfahren zu ihrer Herstellung sowie ihre Verwendung
AT0440081A AT375945B (de) 1981-03-06 1981-10-14 Verfahren zur herstellung von neuen erythromycin a-verbindungen
JP56189381A JPS5858357B2 (ja) 1981-03-06 1981-11-27 新規エリスロマイシンａ誘導体及びその製造法
SE8201311A SE457084B (sv) 1981-03-06 1982-03-03 N-metyl-11-aza-10-deoxo-10-dihydroerytromycin a och derivat samt foerfarande foer framstaellning daerav
CA000397477A CA1191843A (en) 1981-03-06 1982-03-03 Erythromycin a compounds, a process for the manufacture thereof and the use of the new compounds in the control of bacteria
FR8203601A FR2501212B1 (fr) 1981-03-06 1982-03-04 Nouveaux composes d'erythromycines a, procede pour leur fabrication et application de ces nouveaux composes a la lutte contre les bacteries
DD82237882A DD202437A5 (de) 1981-03-06 1982-03-04 Neue erythromycin a-verbindungen, verfahren zu ihrer herstellung sowie die verwendung der neuen verbindungen zur kontrolle von bakterien
BE0/207464A BE892357A (fr) 1981-03-06 1982-03-04 Nouveaux derives de l'erythromycine a, procede pour leur preparation et leur utilisation comme substances anti-bacteriennes
CH1363/82A CH655728A5 (de) 1981-03-06 1982-03-05 Erythromycin a-verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung.
PL1982235329A PL131784B1 (en) 1981-03-06 1982-03-05 Method of manufacture of novel derivatives of erythromycin a
PL1982244022A PL133764B1 (en) 1981-03-06 1982-03-05 Method of obtaining new derivatives of erythromycin a
SU823402600A SU1287755A3 (ru) 1981-03-06 1982-03-05 Способ получени @ -метил-11-аза-10-деоксо-10-дигидро-эритромицина @
HU82683A HU186845B (en) 1981-03-06 1982-03-05 Process for producing new erythromycin compounds and pharmaceutical compositions containing them as active agents
IT67263/82A IT1200960B (it) 1981-03-06 1982-03-05 Nuovi composti dell eritromicina e procedimento per la loro preparazione ed impiego dei nuovi composti per il controllo di batteri
SK4189-91A SK418991A3 (en) 1981-03-06 1991-12-31 N-methyl-11-axa-10-deoxo-10-dihydro erythromycin a and derivatives of this compound
CS914189A CZ418991A3 (en) 1981-03-06 1991-12-31 N-methyl-11-aza-10-deoxo-10-dihydro erythromycin a, and derivatives thereof
HRP-592/81A HRP930015B1 (en) 1981-03-06 1993-01-08 Process for the preparation of n-methyl-11-aza-10-deoxo-10-dihydroerythromicin as well as its derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU592/81A YU43006B (en) 1981-03-06 1981-03-06 Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof

Publications (2)

Publication Number Publication Date
YU59281A YU59281A (en) 1983-06-30
YU43006B true YU43006B (en) 1989-02-28

Family

ID=25550598

Family Applications (1)

Application Number Title Priority Date Filing Date
YU592/81A YU43006B (en) 1981-03-06 1981-03-06 Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof

Country Status (19)

Country Link
US (1) US4517359A (de)
JP (1) JPS5858357B2 (de)
AT (1) AT375945B (de)
BE (1) BE892357A (de)
CA (1) CA1191843A (de)
CH (1) CH655728A5 (de)
CZ (1) CZ418991A3 (de)
DD (1) DD202437A5 (de)
DE (1) DE3140449C2 (de)
FR (1) FR2501212B1 (de)
GB (1) GB2094293B (de)
HU (1) HU186845B (de)
IT (1) IT1200960B (de)
PL (2) PL131784B1 (de)
SE (1) SE457084B (de)
SI (1) SI8110592A8 (de)
SK (1) SK418991A3 (de)
SU (1) SU1287755A3 (de)
YU (1) YU43006B (de)

Families Citing this family (153)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
ZA835204B (en) * 1982-07-19 1985-02-27 Pfizer N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
US4492688A (en) * 1983-11-25 1985-01-08 Pfizer Inc. Antibacterial cyclic ethers of 9-deoxo-9a-aza-9a-homoerythromycin A and intermediates therefor
JPS59225198A (ja) * 1983-05-23 1984-12-18 フアイザ−・インコ−ポレ−テツド 抗菌性を有する９―デオキソ―９ａ―アザ―９ａ―ホモエリスロマイシンＡ，その製造方法および組成物
DE3461803D1 (en) * 1983-05-23 1987-02-05 Pfizer Antibacterial cyclic ethers of 9-deoxo-9a-aza-9a-homoerythromycin a and intermediates therefor
US4464527A (en) * 1983-06-30 1984-08-07 Pfizer Inc. Antibacterial 9-deoxo-9a-alkyl-9a-aza-9a-homoerythromycin A derivatives and intermediates therefore
DE3475073D1 (en) * 1983-09-06 1988-12-15 Pfizer Azahomoerythromycin b derivatives and intermediates thereof
US4465674A (en) * 1983-09-06 1984-08-14 Pfizer Inc. Azahomoerythromycin D derivative and intermediates therefor
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US4921947A (en) * 1986-03-31 1990-05-01 Eli Lilly And Company Process for preparing macrolide derivatives
RO107257B1 (ro) 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US6017894A (en) * 1988-08-03 2000-01-25 Schering Corporation Actinomadura fulva subsp uruguayensis and antimicrobial complex and antimicrobial compounds isolated therefrom
YU45590A (sh) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
TW271400B (de) * 1992-07-30 1996-03-01 Pfizer
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
EP0699207B1 (de) * 1993-05-19 1997-06-25 Pfizer Inc. Zwischenprodukt für azithromycin
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
KR970702725A (ko) * 1994-04-26 1997-06-10 노부히로 나리따 비소세포 폐암 치료용 의약 조성물(Medicinal Composition as a Remedy for Nonsmall Cell Lung Cancer)
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
EP0758244B2 (de) 1994-05-06 2008-02-13 Pfizer Inc. Azithromycin enthaltende arzneiverabreichungsformen mit gesteuerter wirkstoffabgabe
RU2144924C1 (ru) * 1996-06-21 2000-01-27 Зинченко Евгений Яковлевич Способ получения азитромицина и способы получения промежуточных соединений
ES2122905B1 (es) * 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
PT102006B (pt) * 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
SI1036083T1 (en) * 1997-10-16 2004-10-31 Pliva-Istra�iva�ki institut d.o.o. Novel 9a-azalides
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
TW546302B (en) 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (de) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11-Carbamate von antibakteriellen Makroliden
US6245903B1 (en) 1998-08-21 2001-06-12 Apotex, Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
WO2000017218A1 (en) 1998-09-22 2000-03-30 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
KR20010083944A (ko) * 1998-11-03 2001-09-03 실버스타인 아써 에이. 신규 마크롤라이드 항생물질
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
AU768219B2 (en) 1998-11-30 2003-12-04 Teva Pharmaceutical Industries Ltd. Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
TR200102129T2 (tr) 1998-12-10 2002-01-21 Pfizer Products Inc. Karbamat ve karbazat ketolid antibiyotikleri.
CA2359708C (en) * 1999-01-27 2005-10-25 Pfizer Products Inc. Ketolide antibiotics
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
EA200100983A1 (ru) * 1999-05-24 2002-10-31 Пфайзер Продактс Инк. Производные 13-метилэритромицина
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
EP1101769A3 (de) 1999-11-18 2001-10-24 Pfizer Products Inc. Stickstoff-enthaltend Erythromycin-Derivate
ES2177373B1 (es) * 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
CA2396426A1 (en) * 2000-01-04 2001-07-12 Teva Pharmaceutical Industries Ltd. Preparation method of azithromycin dihydrate
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
DE10030781A1 (de) * 2000-06-29 2002-01-17 Hassan Jomaa Kombinationspräparate von 3-N-Formylhydroxylaminopropylphosphonsäurederivaten oder 3-N-Acetylhydroxylaminopropylphosphonsäurederivaten mit spezielen pharmazeutischen Wirkstoffen
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
ES2260047T3 (es) 2000-07-25 2006-11-01 Laboratorio Silanes, S.A. De C.V. Proceso de etapa unica para la preparacion de 7,16-deoxi-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihidroxi-6-etil-3,5,9,11,13,15-hexametilbiciclo(11.2.1)hexadeca-1(2)-en-ona y obtencion de una forma nueva de 9-deoxo-9a-metil-9a-homoeritromicina a.
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
WO2002015842A2 (en) * 2000-08-23 2002-02-28 Wockhardt Limited Process for preparation of anhydrous azithromycin
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
EE05200B1 (et) 2000-11-27 2009-08-17 Biochemie S.A. Asitromtsiin monohdraadina, selle valmistamismeetod ja selle kasutamine ravimkoostises
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
JP4104463B2 (ja) 2001-04-27 2008-06-18 ファイザー・プロダクツ・インク ４’’−置換された−９−デオキソ−９ａ−アザ−９ａ−ホモエリスロマイシン誘導体を製造するための方法
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
US6861413B2 (en) * 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
EP1652851A1 (de) 2001-05-22 2006-05-03 Pfizer Products Inc. Neue Kristallforme von Azithromycin
DK1390377T3 (da) * 2001-05-22 2006-06-19 Pfizer Prod Inc Ny krystalform af azithromycin
EP1418924A2 (de) * 2001-08-21 2004-05-19 Pfizer Products Inc. Einzeldosis azithromycin zur behandlung von respiratorischen infektionen
EP1446010B1 (de) * 2001-10-18 2009-04-15 Teva Pharmaceutical Industries Ltd. Stabilisierte azithromycin-zusammensetzungen
US20080149521A9 (en) * 2001-10-18 2008-06-26 Michael Pesachovich Methods of stabilizing azithromycin
WO2003048786A2 (en) * 2001-11-30 2003-06-12 Bristol-Myers Squibb Company Pipette configurations and arrays thereof for measuring cellular electrical properties
WO2003070173A2 (en) * 2002-02-15 2003-08-28 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
AU2003211113B2 (en) * 2002-02-15 2007-08-09 Merckle Gmbh Antibiotic conjugates
US20040186063A1 (en) * 2002-02-15 2004-09-23 Hans-Jurgen Gutke Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
AU2003219770B2 (en) 2002-02-15 2008-10-09 Merckle Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
EP2316468A1 (de) 2002-02-22 2011-05-04 Shire LLC Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Dextroamphetamin
JPWO2003072589A1 (ja) * 2002-02-26 2005-06-16 明治製菓株式会社 新規１５員環アザライド及び新規１６員環ジアザライド誘導体とその製造法
ITMI20021209A1 (it) * 2002-06-04 2003-12-04 Chemi Spa Processo di preparazione di azitromicina ad elevata purezza
US20040043073A1 (en) * 2002-06-14 2004-03-04 Chih-Ming Chen Pharmaceutical compositions for drugs having pH-dependent solubility
RU2223103C1 (ru) * 2002-07-17 2004-02-10 Открытое акционерное общество "Биосинтез" Фармацевтическая композиция, обладающая антибактериальным действием
US6855813B2 (en) * 2002-07-19 2005-02-15 Alembic Limited Process for the preparation of azithromycin monohydrate
HRP20020614A2 (en) * 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
ITMI20022292A1 (it) 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
WO2004087729A1 (en) * 2003-03-25 2004-10-14 Teva Pharmaceutical Industries Ltd. Degradation products of azithromycin, and methods for their identification
US6645941B1 (en) * 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
ES2220229B1 (es) * 2003-05-29 2005-10-16 Quimica Sintetica, S.A. Sales de adicion de azitromicina y acido citrico y procedimiento para su obtencion.
US7476403B2 (en) * 2003-06-16 2009-01-13 Andrx Pharmaceuticals, Llc Oral extended-release composition
GB2395482A (en) * 2003-07-03 2004-05-26 Jubilant Organosys Ltd Process for preparing non-hygroscopic azithromycin dihydrate
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005009365A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CA2533358C (en) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
US8758820B2 (en) 2003-08-11 2014-06-24 Shionogi Inc. Robust pellet
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JPWO2005019238A1 (ja) * 2003-08-22 2006-10-19 明治製菓株式会社 新規アザライド及びアザラクタム誘導体とその製造法
US8246996B2 (en) 2003-08-29 2012-08-21 Shionogi Inc. Antibiotic product, use and formulation thereof
JP2007513869A (ja) 2003-09-15 2007-05-31 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
US7276487B2 (en) * 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
US20050101547A1 (en) * 2003-11-06 2005-05-12 Sadatrezaei Mohsen Stabilized azithromycin composition
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
ATE399536T1 (de) * 2003-12-04 2008-07-15 Pfizer Prod Inc Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
EP1694304A2 (de) * 2003-12-04 2006-08-30 Pfizer Products Inc. Multiteilchenförmige dosierformen von azithromycin durch verfahren auf flüssigkeitsbasis
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
CA2549225A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
BRPI0416534A (pt) * 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
CN1889931A (zh) * 2003-12-04 2007-01-03 辉瑞产品公司 利用挤压器制备优选含泊洛沙姆和甘油酯的多重粒子阿奇霉素组合物的喷雾－冻凝方法
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
RU2258070C1 (ru) * 2004-01-29 2005-08-10 Открытое акционерное общество "Акционерное курганское общество медицинских препаратов и изделий "Синтез" Способ получения азитромицина
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
WO2006011160A1 (en) * 2004-06-28 2006-02-02 Alembic Limited Process for the preparation of azithromycin monohydrate isopropanol clathrate
JP3933683B2 (ja) * 2004-07-02 2007-06-20 わかもと製薬株式会社 アジスロマイシン含有水性医薬組成物及びその調製方法
US8715727B2 (en) 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
UA85937C2 (uk) 2004-12-21 2009-03-10 Пфайзер Продактс Інк. Макроліди
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US20090318375A1 (en) * 2005-06-08 2009-12-24 Hanmi Pharm Co., Ltd Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
WO2007012464A1 (en) * 2005-07-26 2007-02-01 Merckle Gmbh Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
JP5015016B2 (ja) * 2006-02-07 2012-08-29 大正製薬株式会社 １０ａ−アザライド化合物
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2008023248A2 (en) 2006-08-24 2008-02-28 Wockhardt Research Centre Novel macrolides and ketolides having antimicrobial activity
US7704959B2 (en) 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
US8293715B2 (en) * 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
US20090062220A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched azithromycin
US8299035B2 (en) * 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
JP2012505223A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 薬物動態の改善のためのエアゾールフルオロキノロン配合物
EP2346509B1 (de) 2008-10-07 2020-05-13 Horizon Orphan LLC Inhalation von levofloxacin zur reduzierung von lungenentzündung
US20170128481A9 (en) 2009-03-06 2017-05-11 Insite Vision Corporation Ocular treatment with reduced intraocular pressure
WO2011015219A1 (en) 2009-08-06 2011-02-10 Shifa Pharmed Industrial Group Co. Process for the purification of azithromycin by separation from its thermal degradation products and/or isomers
RU2563809C2 (ru) 2009-09-04 2015-09-20 Мпекс Фармасьютикалс, Инк. Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза
WO2012076989A1 (en) 2010-12-09 2012-06-14 Wockhardt Limited Ketolide compounds
AR085286A1 (es) 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
KR101567658B1 (ko) 2011-03-01 2015-11-09 욱크하르트 리미티드 케톨리드 중간체의 제조 방법
CN103619863B (zh) 2011-03-22 2016-03-16 沃克哈特有限公司 酮内酯化合物的制备方法
WO2013088274A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
CA2894992A1 (en) 2012-12-24 2014-07-03 Ramot At Tel-Aviv University Ltd. Agents for treating genetic diseases resulting from nonsense mutations, and methods for identifying the same
US9044508B2 (en) 2013-03-15 2015-06-02 Insite Vision Corporation Concentrated aqueous azalide formulations
US20150141328A1 (en) * 2013-11-18 2015-05-21 The Schepens Eye Research Institute Stimulation of human meibomian gland function
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
CN104910222B (zh) * 2015-06-29 2018-02-13 石药集团欧意药业有限公司 阿奇霉素新晶型化合物及其制备方法
CN105061528B (zh) * 2015-08-05 2017-10-17 浙江维康药业股份有限公司 一种阿奇霉素化合物及含有该化合物的阿奇霉素软胶囊
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681326A (en) * 1971-01-11 1972-08-01 Abbott Lab 9-substituted erythromycin a and b oximes
SI7910768A8 (en) * 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
US4283527A (en) * 1980-04-01 1981-08-11 Pfizer Inc. Erythromycylamine 11,12-carbonate and derivatives thereof

Also Published As

Publication number Publication date
BE892357A (fr) 1982-07-01
SU1287755A3 (ru) 1987-01-30
FR2501212A1 (fr) 1982-09-10
IT1200960B (it) 1989-01-27
PL133764B1 (en) 1985-06-29
HU186845B (en) 1985-09-30
DE3140449A1 (de) 1983-10-13
SE8201311L (sv) 1982-09-07
JPS57158798A (en) 1982-09-30
YU59281A (en) 1983-06-30
DE3140449C2 (de) 1984-06-20
AT375945B (de) 1984-09-25
PL235329A1 (de) 1982-09-27
PL131784B1 (en) 1985-01-31
SE457084B (sv) 1988-11-28
CA1191843A (en) 1985-08-13
GB2094293A (en) 1982-09-15
JPS5858357B2 (ja) 1983-12-24
US4517359A (en) 1985-05-14
SK418991A3 (en) 1995-07-11
ATA440081A (de) 1984-02-15
CH655728A5 (de) 1986-05-15
IT8267263A0 (it) 1982-03-05
GB2094293B (en) 1985-12-18
FR2501212B1 (fr) 1985-08-09
SI8110592A8 (en) 1996-06-30
CZ418991A3 (en) 1993-01-13
DD202437A5 (de) 1983-09-14

Similar Documents

Publication Publication Date Title
YU59281A (en) Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
DE3270360D1 (en) Cephalosporin derivatives, and process for their preparation
EP0215355A3 (en) Erythromycin derivative and process for preparing the same
IL67022A (en) 2-halo-3-chloro-5-haloalkylpyridines and process for their preparation
PH19919A (en) Macrocin derivatives and process for their preparation
HU185109B (en) Process for preparing imidazo-quinazoline derivatives
PT78141A (en) Process for preparing c-20 and c-23-modified macrolide derivatives
YU42841B (en) Process for obtaining 9-dihydro-11,12-ketal derivatives of erythromycin a and api-erythromycin a
DE3269361D1 (en) Process for producing 7-octen-1-al and derivatives thereof
PH17747A (en) Imidazoline derivatives and process for their preparation
PL238159A1 (en) Process for preparing novel /e/-5-/2-bromovinyl/-uridine and its derivatives
DE3166969D1 (en) 6-quinazolinesulfonyl derivatives and process for preparation thereof
GB2108491B (en) Process for preparing 3-exo-methylenecepham derivatives
PT74674B (en) Process for preparing pyridine derivatives
DE3264631D1 (en) 4-halogenostilbene derivatives and process for their preparation
HUT36184A (en) Process for preparing macrolide derivatives
DE3264841D1 (en) 4-chloro-4-chloromethyloxetan-2-one and process for its preparation
IL67581A (en) Aminopropylaminobleomycin derivatives and process for preparation thereof
PL249198A1 (en) Process for preparing n-phosphonmethylglycine and its derivatives
GB2108492B (en) Process for preparing oxazolineazetidinone derivatives
IL65539A0 (en) New 13-thia-prostacycline derivatives and process for the preparation thereof
GB2108110B (en) Process for preparing 2-oxycephalosporin derivatives
GB2114978B (en) Microbiological process for preparing nebramycin-2 nebramycin-5 and nebramycin-4
IL65491A0 (en) 4-oxo-pgi2 derivatives and process for the preparation thereof
DE3260872D1 (en) Novel thienyloxazolylacetic acid derivatives and process for preparing same